compare glp 1 agonists Comparing GLP-type therapies for weight loss in those without diabetes. Two glucagon-like peptide-1 receptor (GLP-1 RAs) (#semaglutide and #liraglutide) and one dual agonist (#tirzepatide) have been FDA-approved for #weightloss in adults GLP-1 Receptor Agonists and Research

Additionally, liraglutide and semaglutide are approved to reduce CVD risk in patients with CVD and T2DM

GLP-1 receptor agonists are a class of medications that mimic the glucagon-like peptide-1 hormone, enhancing insulin secretion, suppressing glucagon release, and slowing gastric emptying to lower blood glucose levels

[DOI] [PMC free article] [PubMed] [Google Scholar] 30.Knowles NG, Landchild MA, Fujimoto WY, Kahn SE

Personalized treatment and better education for physicians on obesity management are key to improving treatment outcomes

Heres what you need to know: Protein is essential : Aim for at least 60 grams daily to preserve muscle during weight loss